We are live on ! Find out more
8KM

8 Knots Management Portfolio holdings

AUM $868M
1-Year Est. Return 30.97%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+30.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$884M
AUM Growth
+$186M
Cap. Flow
+$117M
Cap. Flow %
13.2%
Top 10 Hldgs %
83.83%
Holding
27
New
11
Increased
3
Reduced
4
Closed
8

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$158M
2
UNH icon
UnitedHealth
UNH
+$83.2M
3
CVS icon
CVS Health
CVS
+$80.5M
4
ELV icon
Elevance Health
ELV
+$55.3M
5
HCSG icon
Healthcare Services Group
HCSG
+$50M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$108M
2
EHC icon
Encompass Health
EHC
+$78.6M
3
CAH icon
Cardinal Health
CAH
+$50.3M
4
PINC
Premier
PINC
+$37.2M
5
ALHC icon
Alignment Healthcare
ALHC
+$31.5M

Sector Composition

Rank Sector Weight
1 Healthcare 98.07%
2 Financials 1.14%
3 Consumer Discretionary 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNC icon
1
Centene
CNC
$30.7B
$187M 21.11%
+5,231,550
New +$158M
UNH icon
2
UnitedHealth
UNH
$385B
$95M 10.74%
+275,022
New +$83.2M
CVS icon
3
CVS Health
CVS
$137B
$88.6M 10.02%
+1,174,797
New +$80.5M
LH icon
4
Labcorp
LH
$25.4B
$58.8M 6.65%
204,859
+100,675
+97% +$27M
ELV icon
5
Elevance Health
ELV
$82.2B
$57.5M 6.5%
+177,950
New +$55.3M
HCSG icon
6
Healthcare Services Group
HCSG
$1.59B
$56.5M 6.39%
+3,358,681
New +$50M
DGX icon
7
Quest Diagnostics
DGX
$26B
$52.5M 5.94%
275,344
+98,806
+56% +$17.5M
BTSG icon
8
BrightSpring Health Services
BTSG
$13.9B
$51.2M 5.8%
+1,733,548
New +$40.3M
ALHC icon
9
Alignment Healthcare
ALHC
$3.83B
$50.5M 5.71%
2,893,093
-2,122,788
-42% -$31.5M
PNTG icon
10
Pennant Group
PNTG
$1.44B
$43.9M 4.97%
1,741,555
-911,251
-34% -$22.3M
EHAB
11
DELISTED
Enhabit
EHAB
$33.8M 3.82%
4,218,846
+365,779
+9% +$2.75M
THC icon
12
Tenet Healthcare
THC
$22.3B
$29.9M 3.38%
147,172
-128,387
-47% -$22.8M
HCA icon
13
HCA Healthcare
HCA
$91.9B
$22.9M 2.59%
+53,641
New +$20.8M
EVH icon
14
Evolent Health
EVH
$385M
$15M 1.69%
1,768,113
-1,145,022
-39% -$11.1M
MCK icon
15
McKesson
MCK
$105B
$13.6M 1.54%
+17,596
New +$12.4M
EHTH icon
16
eHealth
EHTH
$42.2M
$10.1M 1.14%
2,332,017
SCI icon
17
Service Corp International
SCI
$11.7B
$7M 0.79%
+84,062
New +$6.71M
ADUS icon
18
Addus HomeCare
ADUS
$2.24B
$6.08M 0.69%
+51,491
New +$5.78M
SGRY icon
19
Surgery Partners
SGRY
$2.11B
$4.76M 0.54%
+220,088
New +$4.91M
ACHC icon
20
Acadia Healthcare
ACHC
$2.56B
-844,850
Closed -$19.2M
CAH icon
21
Cardinal Health
CAH
$54.3B
-299,258
Closed -$50.3M
CI icon
22
Cigna
CI
$78.7B
-79,617
Closed -$26.3M
EHC icon
23
Encompass Health
EHC
$11.4B
-641,314
Closed -$78.6M
HUM icon
24
Humana
HUM
$43.5B
-441,623
Closed -$108M
PINC
25
DELISTED
Premier
PINC
-1,694,066
Closed -$37.2M

Similar funds

8 Knots Management's Q3 2025 Portfolio in Review

As of Q3 2025, 8 Knots Management held 27 positions worth $884M, up 27% from $698M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

8 Knots Management deployed $117M of net new capital in Q3 2025, opening 11 new positions and adding to 3 existing holdings. Its largest new stake was Centene: 5,231,550 shares worth $187M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 99% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Alignment Healthcare, an estimated $31.5M trimmed.

  • 8 Knots Management's largest Q3 2025 buy was Centene: 5,231,550 shares worth $187M.
  • 8 Knots Management added most to Labcorp in Q3 2025, an estimated $27M increase.
  • 8 Knots Management's biggest Q3 2025 reduction was Alignment Healthcare, cutting an estimated $31.5M.
  • 8 Knots Management fully exited Humana in Q3 2025, selling an estimated $108M.
  • 8 Knots Management's ten largest holdings make up 84% of its $884M portfolio in Q3 2025.
  • 8 Knots Management opened 11 new positions and closed 8 in Q3 2025.
  • 8 Knots Management's portfolio value rose 27% quarter-over-quarter to $884M.

Based on 8 Knots Management's 13F filing for Q3 2025, filed 14 Nov 2025.